- Home
- DORM vs GH Comparison
DORM vs GH Comparison
Compare DORM & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DORM
- GH
- Stock Information
- Founded
- DORM 1978
- GH 2011
- Country
- DORM United States
- GH United States
- Employees
- DORM N/A
- GH N/A
- Industry
- DORM Auto Parts:O.E.M.
- GH Medical Specialities
- Sector
- DORM Consumer Discretionary
- GH Health Care
- Exchange
- DORM Nasdaq
- GH Nasdaq
- Market Cap
- DORM 4.2B
- GH 4.7B
- IPO Year
- DORM 1991
- GH 2018
- Fundamental
- Price
- DORM $129.60
- GH $36.66
- Analyst Decision
- DORM Strong Buy
- GH Strong Buy
- Analyst Count
- DORM 2
- GH 14
- Target Price
- DORM $121.50
- GH $39.93
- AVG Volume (30 Days)
- DORM 165.4K
- GH 1.9M
- Earning Date
- DORM 02-24-2025
- GH 02-20-2025
- Dividend Yield
- DORM N/A
- GH N/A
- EPS Growth
- DORM 95.21
- GH N/A
- EPS
- DORM 5.97
- GH N/A
- Revenue
- DORM $1,969,721,000.00
- GH $692,256,000.00
- Revenue This Year
- DORM $5.71
- GH $32.21
- Revenue Next Year
- DORM $3.48
- GH $16.90
- P/E Ratio
- DORM $21.70
- GH N/A
- Revenue Growth
- DORM 1.70
- GH 29.20
- 52 Week Low
- DORM $79.43
- GH $15.81
- 52 Week High
- DORM $146.60
- GH $39.29
- Technical
- Relative Strength Index (RSI)
- DORM 49.27
- GH 61.33
- Support Level
- DORM $119.28
- GH $34.80
- Resistance Level
- DORM $130.87
- GH $39.29
- Average True Range (ATR)
- DORM 3.11
- GH 1.92
- MACD
- DORM 0.24
- GH 0.30
- Stochastic Oscillator
- DORM 73.77
- GH 71.96
About DORM Dorman Products Inc.
Dorman Products Inc is a supplier of original equipment parts for automobiles. The company produces automotive and heavy-duty replacement parts, automotive hardware, brake parts, and fasteners for the automotive and heavy-duty aftermarket. The products are sold under the Dorman brand and its sub-brands OE Solutions, Help!, Conduct-Tite, and HD Solutions through aftermarket retailers, regional and local warehouse distributors, specialty markets, and salvage yards. It operates as a single reportable operating segment, namely, the sale of replacement and upgrades parts in the motor vehicle aftermarket industry, serving passenger cars, light-, medium-, and heavy-duty trucks as well as specialty vehicles. The company operates in the United States.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.